Drugs / HDV-Interferon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00703872 | May 2008 → Dec 2009 | chronic hepatitis C virus infection | Hepasome Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HDV-Interferon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00703872 ↗ |
| Known as | HDV-IFN | “treatment with HDV-Interferon (HDV-IFN), by oral or subcutaneous (injection) routes, and ribavirin” NCT00703872 ↗ |
| Route | Oral | “HDV-Interferon (HDV-IFN), orally” NCT00703872 ↗ |